Sector Watch: Healthcare - Sep 04 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $121.00 -1.19 -0.97% | XBI: $100.01 -0.13 -0.13% | Updated Sep 04, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| MNKD MannKind $318.2M |
2.08+0.98 50.8 M 27.2x |
89% | ||
| REPH Recro Pharma $167.2M |
8.07+1.69 1.8 M 17.7x |
26% | ||
| BVX52WH Bovie Medical $205.5M |
6.19+0.85 1.2 M 9.0x |
16% | ||
| ABUS Arbutus Biopharma $567.9M |
10.25+1.15 1.6 M 4.4x |
13% | ||
| IRMD52WH IRadimed $323.1M |
30.25+2.75 251.3 K 2.2x |
10% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| AGLE Aeglea BioTherapeutics $203.2M |
9.24-1.69 1.0 M 6.9x |
-15% | ||
| CYH Community Health Systems $411.5M |
3.54-0.34 2.2 M |
-9% | ||
| CVRS Corindus Vascular Robotics $190.9M |
1.00-0.09 523.6 K |
-8% | ||
| ADVM Adverum Biotechnologies $438.9M |
7.00-0.60 710.6 K |
-8% | ||
| NTEC52WL Intec Pharma $131.2M |
3.65-0.30 312.4 K 3.9x |
-8% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
United Therapeutics and MannKind Announce Collaboration for Pulmonary Hypertension Products [globenewswire.com]Recro Pharma Provides Regulatory Update for IV Meloxicam Nasdaq:REPH [globenewswire.com]
Bovie Medical Corporation Announces Completion of ?Core? Business Segment Sale to Symmetry Surgical, Inc. for Total Cash Consideration of $97 Million | Business Wire [businesswire.com]
Community Health Systems to Participate in Baird 2018 Global Healthcare Conference | Business Wire [businesswire.com]
RoundTable Healthcare Partners and Symmetry Surgical Inc. Complete Acquisition of Bovie Medical's Electrosurgical Business [prnewswire.com]
United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products [prnewswire.com]
Adverum Biotechnologies Announces IND Active for ADVM-022, a Novel Gene Therapy to Treat Wet Age-related Macular Degeneration [globenewswire.com]
Community Health Systems to Participate in 2018 Wells Fargo Securities Healthcare Conference | Business Wire [businesswire.com]
The Alliance for Regenerative Medicine Releases Agenda for 2018 Cell & Gene Meeting on the Mesa [globenewswire.com]
MannKind Corporation to Present at Upcoming Conferences [globenewswire.com]
Arbutus to Participate at the 2018 B. Riley FBR Healthcare Conference [globenewswire.com]
Aeglea BioTherapeutics to Present at 2018 Wells Fargo Healthcare Conference [globenewswire.com]
Analysis: Positioning to Benefit within MannKind, Chimerix, Superior Energy Services, Marinus Pharmaceuticals, Airgain, and Eagle Pharmaceuticals ? Research Highlights Growth, Revenue, and Consolidated Results [globenewswire.com]
Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 SSIEM Annual Symposium [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
